cqp 201-403 has been researched along with ergoline in 12 studies
| Studies (cqp 201-403) | Trials (cqp 201-403) | Recent Studies (post-2010) (cqp 201-403) | Studies (ergoline) | Trials (ergoline) | Recent Studies (post-2010) (ergoline) |
|---|---|---|---|---|---|
| 12 | 4 | 0 | 4,324 | 381 | 441 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ettenger, RB; Koyle, MA; Rosenthal, JT; Wilner, ML | 1 |
| Davis, JR; Sheppard, MC; Vidal, ME; Wilson, EM | 1 |
| Glaeske, CS; Herrera, LH; Hofman, RE; Pfeiffer, RF | 1 |
| Brownell, J; Rolland, R; van der Heijden, PF | 1 |
| Brownell, J; Gaillard, RC | 1 |
| Brownell, J; Halse, J; Hanssen, LE; Jervell, J; Reinlie, S; Stokke, KT; Stray-Pedersen, S | 1 |
| Briner, U; Clark, B; Closse, A; Enz, A; Flückiger, E; Gull, P; Hofmann, A; Markstein, R; Tolcsvai, L; Wagner, HR | 1 |
| Adams, EF; Brownell, J; Burrin, JM; Venetikou, MS; Woods, CA; Yeo, TH | 1 |
| Brownell, J; Gaillard, RC; Grevel, J; Rosenthaler, J; Steimer, JL | 1 |
| Blake, MJ; Buckley, AR; Buckley, DJ | 1 |
| Ferrari, F; Giuliani, D; Pelloni, F | 1 |
| Ferrari, F; Giuliani, D; Ottani, A | 1 |
4 trial(s) available for cqp 201-403 and ergoline
| Article | Year |
|---|---|
Prolactin suppressant effect of CQP 201-403, a new dopamine agonist, in hyperprolactinemic women.
Topics: Clinical Trials as Topic; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Hormones; Humans; Hyperprolactinemia; Prolactin; Random Allocation | 1987 |
Hormonal effects of CQP 201-403, a new dopamine agonist.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Ergolines; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Prolactin; Pulse; Sleep; Thyrotropin; Time Factors | 1988 |
CQP 201-403, a new dopamine agonist in the treatment of hyperprolactinemia.
Topics: Adult; Clinical Trials as Topic; Ergolines; Fasting; Female; Humans; Hyperprolactinemia; Prolactin | 1988 |
Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201-403 by an integrated pharmacokinetic-pharmacodynamic model.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Humans; Kinetics; Male; Models, Biological; Prolactin; Radioimmunoassay; Random Allocation; Software; Time Factors | 1986 |
8 other study(ies) available for cqp 201-403 and ergoline
| Article | Year |
|---|---|
The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection.
Topics: Animals; Cyclosporins; Dopamine Agents; Ergolines; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lymphocyte Activation; Prolactin; Rats; Rats, Inbred Lew | 1990 |
Suppression of prolactin release and mRNA accumulation by two novel dopamine agonist agents.
Topics: Aminoquinolines; Animals; Cells, Cultured; Cytoplasm; Dopamine Agents; Ergolines; Growth Hormone; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; RNA, Messenger | 1989 |
CQP 201-403 in Parkinson's disease: an open-label pilot study.
Topics: Aged; Dopamine Agents; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects | 1989 |
Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
Topics: Animals; Behavior, Animal; Binding, Competitive; Brain; Cell Membrane; Dogs; Dopamine; Embryo Implantation; Ergolines; Female; Hemodynamics; Lactation; Male; Mice; Milk Ejection; Motor Activity; Norepinephrine; Pregnancy; Prolactin; Rats; Rats, Inbred Strains; Serotonin | 1988 |
Effects of two novel dopaminergic drugs, CV 205-502 and CQP 201-403, on prolactin and growth hormone secretion by human pituitary tumours in vitro.
Topics: Aminoquinolines; Animals; Ergolines; Growth Hormone; Humans; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Tumor Cells, Cultured | 1987 |
Dopaminergic regulation of heat shock protein-70 expression in adrenal gland and aorta.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Aorta; Base Sequence; Dopamine Agents; Ergolines; Female; Gene Expression Regulation; Heat-Shock Proteins; Hypophysectomy; Hypothalamo-Hypophyseal System; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligonucleotide Probes; Pituitary-Adrenal System; Prolactin; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Stress, Psychological | 1993 |
Behavioural profile in the chicken of CQ 32-084 and CQP 201-403, two dopamine agonists.
Topics: Animals; Behavior, Animal; Chickens; Dopamine Agents; Ergolines; Grooming; Hypnotics and Sedatives; Male; Receptors, Dopamine; Sulpiride; Yawning | 1993 |
Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.
Topics: Animals; Behavior, Animal; Cannabinoids; Cocaine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dronabinol; Ergolines; Locomotion; Male; Rats; Rats, Wistar; Stereotyped Behavior | 1999 |